Target
Pro-glucagon
Ligand
BDBM142035
Substrate
n/a
Meas. Tech.
SPA Assay
pH
7.4±n/a
Ki
91±n/a nM
Citation
 Didiuk, MFilipski, KJGuzman-Perez, ALee, ECPfefferkorn, JAStevens, BTu, M Quinolinyl glucagon receptor modulators US Patent  US8927577 Publication Date 1/6/2015 
Target
Name:
Pro-glucagon
Synonyms:
GCG | GLUC_HUMAN | Glucagon | Glucagon receptor (GCGR)
Type:
Enzyme
Mol. Mass.:
20907.95
Organism:
Homo sapiens (Human)
Description:
P01275
Residue:
180
Sequence:
MKSIYFVAGLFVMLVQGSWQRSLQDTEEKSRSFSASQADPLSDPDQMNEDKRHSQGTFTSDYSKYLDSRRAQDFVQWLMNTKRNRNNIAKRHDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGRRDFPEEVAIVEELGRRHADGSFSDEMNTILDNLAARDFINWLIQTKITDRK
  
Inhibitor
Name:
BDBM142035
Synonyms:
US8927577, 16
Type:
Small organic molecule
Emp. Form.:
C25H26F3N3O3
Mol. Mass.:
473.4874
SMILES:
CC(C)CC(Nc1ccc2cc(ccc2n1)C(F)(F)F)c1ccc(cc1)C(=O)NCCC(O)=O
Structure:
Search PDB for entries with ligand similarity: